ScandiDos AB (FRA:2FV) NonCurrent Deferred Liabilities: €0.00 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2FV ScandiDos AB FRA:2FV
47 GF Score
Price €0.05
GF Value €0.06
! 4 Warning Signs
View Full Analysis

What is ScandiDos AB NonCurrent Deferred Liabilities?

ScandiDos AB FRA:2FV -5.21% 47 NonCurrent Deferred Liabilities is €0.00 Mil as of Apr. 2026. GuruFocus rates FRA:2FV with a GF Score™ of 47/100 and a GF Value™ of €0.06. The stock has 4 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

ScandiDos AB's non-current deferred liabilities for the quarter that ended in Apr. 2026 was €0.00 Mil.

ScandiDos AB NonCurrent Deferred Liabilities Related Terms

ScandiDos AB NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for ScandiDos AB's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ScandiDos AB NonCurrent Deferred Liabilities Chart

ScandiDos AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ScandiDos AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:2FV
47GF Score
ScandiDos AB FRA:2FV
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of €0.00 Mil mean?
ScandiDos AB (FRA:2FV) has a NonCurrent Deferred Liabilities of €0.00 Mil as of Apr. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on ScandiDos AB and its competitors.
Is ScandiDos AB's NonCurrent Deferred Liabilities too high?
ScandiDos AB's current NonCurrent Deferred Liabilities is €0.00 Mil. Overall, ScandiDos AB has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does ScandiDos AB's NonCurrent Deferred Liabilities compare to ABT and SYK?
ScandiDos AB's NonCurrent Deferred Liabilities of €0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Devices & Instruments company?
A good NonCurrent Deferred Liabilities depends on the Medical Devices & Instruments industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on ScandiDos AB and its competitors. ScandiDos AB's current NonCurrent Deferred Liabilities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ScandiDos AB stock overvalued right now?
ScandiDos AB (FRA:2FV) has a current NonCurrent Deferred Liabilities of €0.00 Mil. The stock's GF Value™ is €0.06, compared to a current price of €0.05 — trading 24.2% below its estimated fair value. The current NonCurrent Deferred Liabilities is €0.00 Mil. ScandiDos AB's overall GF Score™ is 47/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For ScandiDos AB (FRA:2FV), the current NonCurrent Deferred Liabilities is €0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ScandiDos AB (FRA:2FV) Overvalued in 2026?

Based on GuruFocus' analysis, ScandiDos AB stock appears to be undervalued. The current stock price of €0.05 is trading 24.2% below its estimated GF Value™ of €0.06.

Key valuation signals for FRA:2FV:

  • NonCurrent Deferred Liabilities: €0.00 Mil
  • GF Value™: €0.06 vs. price of €0.05 (24.2% below fair value)
  • GF Score™: 47/100 with 4 warning signs

No single metric tells the full story. See the FRA:2FV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ScandiDos AB Business Description

Other Exchanges SDOS:Sweden
Address Uppsala Science Park, Uppsala, SWE, SE-751 83
ScandiDos AB is engaged in providing radiation therapy for cancer. Its product, Delta4 Phantom+, and its various hardware and software options are at the heart of everything ScandiDos does, from product development and production to marketing, sales, and customer support. With Delta4 HexaMotion ScandiDos has successfully developed a motion platform that recreates the movement of the tumor in six dimensions and independently simulates the patient's breathing movement.
47GF Score

Get the complete analysis for FRA:2FV

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.05
Price
€0.06
GF Value